Troxyca ER

Troxyca ER is a medication used for pain management. Troxyca ER use may lead to life-threatening breathing problems.

Troxyca ER Overview

Reviewed: August 29, 2016
Updated: 

Troxyca ER is a prescription medication used to manage severe pain. It is formulated to deter abuse. 

Troxyca ER is a single product containing 2 medications: oxycodone and naltrexone.

Oxycodone belongs to a group of drugs called opioids. Opioids block the pain signal from reaching the brain, which helps to reduce the perception of pain. Naltrexone belongs to a group of drugs called opiate antagonists. It works by blocking the effects of opioid medications.

This medication comes in capsule form and is to be taken by mouth. The dosing is selected by a prescriber trained in pain management and depends on the severity of pain, response, prior pain management therapies, and risk factors for addiction, abuse, and misuse. The lowest effective dose should be given for the shortest possible duration. 

Swallow capsule whole; do not crush, chew, or dissolve the pellets in capsule.

Common side effects of Troxyca ER include nausea, constipation, vomiting and headache.

Troxyca ER can also cause drowsiness. Do not drive or operate heavy machinery until you know how Troxyca ER affects you. 

 

How was your experience with ?

First, a little about yourself

Tell us about yourself in a few words?

What tips would you provide a friend before taking ?

What are you taking for?

Choose one
  • Other

How long have you been taking it?

Choose one
  • Less than a week
  • A couple weeks
  • A month or so
  • A few months
  • A year or so
  • Two years or more

How well did work for you?

Did you experience many side effects while taking this drug?

How likely would you be to recommend to a friend?

Troxyca ER Cautionary Labels

precautionsprecautionsprecautionsprecautionsprecautionsprecautionsprecautionsprecautions

Uses of Troxyca ER

Troxyca ER is a combination opioid agonist/opioid antagonist product indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. The opioid antagonist component is present to deter abuse. 

Oxycodone and Naltrexone

For more information on this medication choose from the list of selections below.

Troxyca ER Drug Class

Troxyca ER is part of the drug class:

Side Effects of Troxyca ER

Serious side effects have been reported with Troxyca ER. See the “Troxyca ER Precautions” section. 

Common side effects of Troxyca ER include the following: 

  • nausea
  • constipation
  • vomiting
  • headache
  • drowsiness/tiredness
  • dizziness
  • abdominal pain

This is not a complete list of Troxyca ER side effects. Ask your doctor or pharmacist for more information. Tell your doctor if you have any side effect that bothers you or that does not go away. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. 

Troxyca ER Interactions

Central nervous system depressants: could increase risk of breathing problems, coma, and death; includes the following:

  • benzodiazepines such as alprazolam (Xanax), clonazepam (Klonopin), and diazepam (Valium) 
  • sleep medications such as zolpidem (Ambien)
  • muscle relaxants such as carisoprodol and cyclobenzaprine
  • alcohol

Serotonergic medications: medications that could lead to serotonin syndrome such as citalopram (Celexa), escitalopram (Lexapro), fluoxetine (Prozac, Sarafem), fluvoxamine (Luvox), desvenlafaxine (Pristiq), nefazodone, paroxetine (Paxil, Pexeva), sertraline (Zoloft), venlafaxine (Effexor), trimipramine (Surmontil), isocarboxazid (Marplan), amitriptyline (Elavil), nortriptyline (Pamelor, Aventyl), protriptyline (Vivactil), and clomipramine (Anafranil), and linezolid (Zyvox)

Monoamine oxidase inhibitors: a class of antidepressants that includes medications such as tranylcypromine (Parnate), phenelzine (Nardil), selegiline (Eldepryl, Zelapar), isocarboxazid (Marplan), and rasagiline (Azilect)

Mixed Agonist/Antagonist and Partial Agonist Opioids: Avoid use with Troxyca ER because they may reduce effect of Troxyca ER or lead to withdrawal symptoms. 

CYP3A4 inhibitors: medications that block a protein in the body (CYP3A4) such as some macrolide antibiotics (clarithromycin, telithromycin), some HIV protease inhibitors (indinavir, nelfinavir, ritonavir, saquinavir), some HCV protease inhibitors (boceprevir, telaprevir), some azole antifungals (ketoconazole, itraconazole, posaconazole, voriconazole), delavirdine (Rescriptor), and nefazodone.

Troxyca ER Precautions

Serious side effects have been reported with Troxyca ER including the following: 

Addiction, Abuse, and Misuse. Use Troxyca ER exactly how prescribed for the purpose of managing severe pain. Inappropriate use of Troxyca ER can lead to overdose and death. Contact emergency services immediately if you experience any symptoms of overdose such as:

  • difficulty breathing 
  • shallow, infrequent breaths
  • excess sedation
  • loss of consiousness
  • pin-point pupils
  • blue skin

Life-threatening breathing problems (respiratory depression). Contact your healthcare provider right away if you experience any breathing difficulties. 

Neonatal opioid withdrawal syndrome. Use of Troxyca ER during pregnancy can lead to a life-threatening withdrawal syndrome once the baby is born. Do not use Troxyca if you are pregnant or plan to become pregnant. 

Severely low blood pressure (hypotension). Contact your healthcare provider if you experience any signs of hypotension such as:

  • dizziness
  • dizziness upon standing
  • blurred vision
  • lightheadedness
  • nausea
  • cold, clammy, pale skin

Serotonin syndrome. Contact your healthcare provider if you experience any signs of serotonin syndrome such as:

  • agitation or restlessness
  • confusion
  • rapid heart rate and high blood pressure
  • dilated pupils
  • muscle twitches
  • heavy sweating
  • diarrhea

Risks due to interactions with other medications. Interactions with medications can increase the risk of serious, life-threatening side effects. See "Troxyca ER Drug Interactions" for more information. 

Adrenal insufficiency. Contact your healthcare provider if you experience any signs of adrenal insufficiency such as:

  • nausea/vomiting
  • anorexia
  • fatigue
  • weakness
  • dizziness
  • low blood pressure

Increased risk of seizures in those with seizure disorder. Contact your healthcare provider if you have a seizure disorder and experience an increase in seizures.

Troxyca ER Food Interactions

Medications can interact with certain foods. In some cases, this may be harmful and your doctor may advise you to avoid certain foods. In the case of Troxyca ER, there are no specific foods that you must exclude from your diet when receiving this medication. 

Inform MD

Before taking Troxyca ER, tell your doctor about all of your medical conditions. Especially tell your doctor if you have:

  • an allergy to Troxyca ER or to any of its ingredients
  • asthma, trouble breathing, or other lung problems
  • a bowel blockage or have narrowing of the stomach or intestines
  • liver problems
  • kidney problems
  • thyroid problems
  • pancreas or gallbladder problems
  • problems urinating
  • history of head injury or seizures
  • history of abuse of street or prescription drugs, alcohol addiction, or mental health problems

Tell your doctor about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements. 

Troxyca ER and Pregnancy

Tell your healthcare provider if you are pregnant or plan to become pregnant. 

Prolonged use of Troxyca ER during pregnancy can cause withdrawal symptoms in your newborn baby that could be life-threatening if not recognized and treated. 

Troxyca ER and Lactation

Tell your healthcare provider if you are breastfeeding or plan to breastfeed. 

Troxyca ER use is not recommended if you are breastfeeding because it may harm your baby. 

Troxyca ER Usage

  • Take Troxyca ER exactly as prescribed. 
  • This medication comes in capsule form and is to be taken by mouth with or without food. 
  • Swallow capsule whole; do not crush, chew, or dissolve the pellets in capsule due to a risk of fatal oxycodone overdose or naltrexone precipitated withdrawal symptoms in opioid-dependent individuals.
  • If you cannot swallow Troxyca ER capsules whole, tell your healthcare provider. If your healthcare provider approves, you may take Troxyca ER by sprinkling the capsule contents on 1 tablespoon of applesauce. Be sure to swallow all of the contents and rinse mouth with water. Do not chew the contents. 
  • If you miss a dose, take the missed dose as soon as you remember. If it is almost time for the next dose, skip the missed dose and take your next dose at the regular time. Do not take two doses of Troxyca ER at the same time. 
  • Do not discontinue Troxyca ER without first discussing the need for a tapering regimen with your prescriber. 

Troxyca ER Dosage

Take this medication exactly as prescribed by your doctor. Follow the directions on your prescription label carefully.

The dose your doctor recommends may be based on the following:

  • severity of pain
  • response to the medication
  • prior pain management therapies
  • risk factors for addiction, abuse, and misuse
  • other medical conditions
  • other medications used

The dosing is selected by a prescriber trained in pain management. For those who have never used opioids for pain management, the recommended initial dose is 10mg of oxycodone with 1.2mg naltrexone every 12 hours. There is no official maximum dose, but the lowest effective dose should be given for the shortest possible duration. 

Troxyca ER Overdose

If you take too much Troxyca ER, call your healthcare provider or local Poison Control Center, or seek emergency medical attention right away. 

Other Requirements

Store Troxyca ER at room temperature. Keep this and all medicines out of the reach of children. 

Troxyca ER FDA Warning

WARNING: ADDICTION, ABUSE, AND MISUSE; LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; NEONATAL OPIOID WITHDRAWAL SYNDROME; and CYTOCHROME P450 3A4 INTERACTION

  • Troxyca ER exposes users to risks of addiction, abuse, and misuse, which can lead to overdose and death. Assess patient’s risk before prescribing, and monitor regularly for these behaviors and conditions.

  • Serious, life-threatening, or fatal respiratory depression may occur. Monitor closely, especially upon initiation or following a dose increase. Instruct patients to swallow Troxyca ER capsules whole to avoid exposure to a potentially fatal dose of oxycodone.

  • Accidental ingestion of Troxyca ER, especially by children, can result in fatal overdose of oxycodone.

  • Prolonged use of Troxyca ER during pregnancy can result in neonatal opioid withdrawal syndrome, which may be life-threatening if not recognized and treated. If prolonged opioid use is required in a pregnant woman, advise the patient of the risk of neonatal opioid withdrawal syndrome and ensure that appropriate treatment will be available.

  • Concomitant use with CYP3A4 inhibitors (or discontinuation of CYP3A4 inducers) can result in fatal overdose of oxycodone from Troxyca ER.